We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current T1CH34 market cap is 2.21B. The company's latest EPS is USD 1.0668 and P/E is 68.94.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 276.94M | 272.6M | 303.43M | 306.1M | 289.46M |
| Operating Income | 54.27M | 38.89M | 65.25M | 63.4M | 47.78M |
| Net Income | 49.1M | 29.36M | 49.06M | 40.59M | 33.6M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 738.69M | 931.03M | 1.11B | 1.14B | 1.16B |
| Operating Income | 157.42M | 237.3M | 361.57M | 297.8M | 221.81M |
| Net Income | 229.3M | 140.41M | 337.04M | 285.26M | 168.11M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.76B | 2.73B | 2.72B | 2.7B | 2.74B |
| Total Liabilities | 757.61M | 767.19M | 706.8M | 635.02M | 597.37M |
| Total Equity | 2B | 1.96B | 2.01B | 2.07B | 2.14B |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.03B | 2.26B | 2.29B | 2.64B | 2.7B |
| Total Liabilities | 646.4M | 691.72M | 593.79M | 672.18M | 635.02M |
| Total Equity | 1.38B | 1.57B | 1.7B | 1.97B | 2.07B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 59.38M | 142.5M | 223.49M | 298.98M | 63.89M |
| Investing | -154.11M | -177.78M | -194.22M | -203.03M | -21.68M |
| Financing | 71.51M | -9.89M | -62.3M | -122.4M | -11.57M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 205.22M | 352.16M | 325.27M | 254.39M | 298.98M |
| Investing | 27.1M | -243.52M | -96.85M | -265.65M | -203.03M |
| Financing | -183.8M | -62.55M | -242.85M | 22.62M | -122.4M |
| Market Cap | 2.21B |
| Price to Earnings Ratio | 68.94 |
| Price to Sales Ratio | 10 |
| Price to Cash Ratio | 76.36 |
| Price to Book Ratio | 5.6 |
| Dividend Yield | 0.31% |
| Shares Outstanding | 157.59M |
| Average Volume (1 week) | 2 |
| Average Volume (1 Month) | 6 |
| 52 Week Change | 25.22% |
| 52 Week High | 16.38 |
| 52 Week Low | 5.01 |
| Spread (Intraday) | 0.12 (0.85%) |
| Company Name | Bio-Techne Corp |
| Address |
614 mckinley place n.e minneapolis, minnesota 55413 |
| Website | https://www.bio-techne.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
